Neuronetics, Inc. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
Neuronetics, Inc. (STIM) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2026-03-17
- Neuronetics, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2025 was $0.00.
- Neuronetics, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2024 was $0.00.
- Neuronetics, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was $0.00.
- Neuronetics, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2022 was $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-17 |
| 2024-12-31 | $0.00 10-K · filed 2025-03-27 |
| 2023-12-31 | $0.00 10-K · filed 2024-03-08 |
| 2022-12-31 | $0.00 10-K · filed 2023-03-07 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-08 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-02 |
| 2019-12-31 | $0.00 10-K · filed 2020-03-03 |
| 2018-12-31 | $0.00 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |